BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$455M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$333M |
| 3 |
Procter & Gamble
PG
|
+$252M |
| 4 |
iShares Russell 2000 Growth ETF
IWO
|
+$233M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$221M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$829M |
| 2 |
SPDR Gold Trust
GLD
|
+$571M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$190M |
| 4 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$172M |
| 5 |
Alibaba
BABA
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.13% |
| 2 | Financials | 8.84% |
| 3 | Communication Services | 8.45% |
| 4 | Consumer Discretionary | 6.71% |
| 5 | Healthcare | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLNT
3326
Fluent
FLNT
$130M
| $5.25K | ﹤0.01% |
172
+72
| +72% | +$2.21K |
|
3327
Larimar Therapeutics
LRMR
$448M
| $5.14K | ﹤0.01% |
130
+55
| +73% | +$2.5K |
|
3328
Genie Energy
GNE
$384M
| $5.13K | ﹤0.01% |
869
+367
| +73% | +$2.36K |
|
|
CLSD
3329
DELISTED
Clearside Biomedical
CLSD
| $5.12K | ﹤0.01% |
+20
| New | +$2.45K |
|
3330
Townsquare Media
TSQ
$100M
| $5.11K | ﹤0.01% |
547
+246
| +82% | +$2.17K |
|
3331
Lifeway Foods
LWAY
$454M
| $5.1K | ﹤0.01% |
301
+132
| +78% | +$1.6K |
|
3332
Urban One Class D
UONEK
$23.7M
| $5.08K | ﹤0.01% |
168
+70
| +71% | +$2.26K |
|
|
TCS
3333
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $5.04K | ﹤0.01% |
67
+30
| +81% | +$2.42K |
|
3334
Lipocine
LPCN
$17.2M
| $5.02K | ﹤0.01% |
66
+27
| +69% | +$1.67K |
|
3335
Radware
RDWR
$1.2B
| $4.95K | ﹤0.01% |
360
| – | – |
|
|
ABCD
3336
DELISTED
Cambium Learning Group, Inc.
ABCD
| $4.92K | ﹤0.01% |
906
+381
| +73% | +$1.88K |
|
|
PRMW
3337
DELISTED
Primo Water Corporation
PRMW
| $4.9K | ﹤0.01% |
249
| – | – |
|
3338
Carlyle Group
CG
$17.2B
| $4.89K | ﹤0.01% |
314
| – | – |
|
3339
Harte-Hanks
HHS
$18.5M
| $4.87K | ﹤0.01% |
301
-956
| -76% | -$15.7K |
|
3340
Turning Point Brands
TPB
$1.77B
| $4.87K | ﹤0.01% |
405
+169
| +72% | +$2.02K |
|
3341
Syndax Pharmaceuticals
SNDX
$1.81B
| $4.87K | ﹤0.01% |
321
+135
| +73% | +$1.78K |
|
|
UCP
3342
DELISTED
UCP, Inc.
UCP
| $4.85K | ﹤0.01% |
550
+230
| +72% | +$1.93K |
|
|
NCIT
3343
DELISTED
NCI, Inc.
NCIT
| $4.74K | ﹤0.01% |
410
+171
| +72% | +$2.14K |
|
|
GSOL
3344
DELISTED
Global Sources Ltd
GSOL
| $4.73K | ﹤0.01% |
558
+234
| +72% | +$2.05K |
|
|
PVBC
3345
DELISTED
Provident Bancorp
PVBC
| $4.68K | ﹤0.01% |
606
+254
| +72% | +$1.99K |
|
3346
iRadimed
IRMD
$1.14B
| $4.67K | ﹤0.01% |
275
+115
| +72% | +$2.13K |
|
|
RXII
3347
DELISTED
GALENA BIOPHARMA INC COM
RXII
| $4.64K | ﹤0.01% |
13,266
+1,277
| +11% | +$447 |
|
|
HMTV
3348
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $4.64K | ﹤0.01% |
364
+109
| +43% | +$1.36K |
|
|
NYNY
3349
DELISTED
Empire Resorts, Inc.
NYNY
| $4.59K | ﹤0.01% |
227
+95
| +72% | +$1.61K |
|
|
ARGS
3350
DELISTED
Argos Therapeutics, Inc.
ARGS
| $4.57K | ﹤0.01% |
46
+25
| +119% | +$2.61K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2016 Portfolio in Review
As of Q3 2016, BNP Paribas Financial Markets held 3,649 positions worth $24.3B, up 9.6% from $22.2B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
BNP Paribas Financial Markets deployed $743M of net new capital in Q3 2016, opening 86 new positions and adding to 1,696 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 1,600,000 shares worth $238M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.1% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $829M trimmed.
- BNP Paribas Financial Markets's largest Q3 2016 buy was iShares Russell 2000 Growth ETF: 1,600,000 shares worth $238M.
- BNP Paribas Financial Markets added most to iShares Russell 2000 ETF in Q3 2016, an estimated $455M increase.
- BNP Paribas Financial Markets's biggest Q3 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $829M.
- BNP Paribas Financial Markets fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $31.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 32% of its $24.3B portfolio in Q3 2016.
- BNP Paribas Financial Markets opened 86 new positions and closed 106 in Q3 2016.
- BNP Paribas Financial Markets's portfolio value rose 9.6% quarter-over-quarter to $24.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2016, filed 5 Oct 2016.